Differential role of ERK in cAMP-induced Nurr1 expression in N2A and C6 cells

Neuroreport. 2004 Jan 19;15(1):99-102. doi: 10.1097/00001756-200401190-00020.

Abstract

We investigated the signal pathway related to induction of Nurr1, transcription factor, by cAMP in neuroblastoma N2A and C6 glioma cell lines. Nurr1 expression was induced by forskolin, an adenylate cyclase activator, via activation of CREB in both N2A and C6 cells. The effect of forskolin on ERK, however, was cell specific. ERK phosphorylation was stimulated by forskolin in N2A cells whereas it was inhibited in C6 cells. Pretreatment with H89, a PKA inhibitor, blocked the forskolin-induced Nurr1 expression in both N2A and C6 cells. Interestingly, pretreatment with PD98059, an MEK inhibitor, showed differential effects. Pretreatment with PD98059 inhibited the forskolin-induced Nurr1 expression in N2A cells, however, in C6 cells, Nurr1 expression was further increased. Our results suggest that ERK pathway plays a differential role in cAMP-induced Nurr1 expression in N2A and C6 cells.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Colforsin / pharmacology
  • Cyclic AMP / agonists
  • Cyclic AMP / metabolism*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • DNA-Binding Proteins / biosynthesis*
  • DNA-Binding Proteins / genetics
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology
  • Mice
  • Mitogen-Activated Protein Kinases / physiology*
  • Nuclear Receptor Subfamily 4, Group A, Member 2
  • Rats
  • Transcription Factors / biosynthesis*
  • Transcription Factors / genetics

Substances

  • Cyclic AMP Response Element-Binding Protein
  • DNA-Binding Proteins
  • Nr4a2 protein, mouse
  • Nr4a2 protein, rat
  • Nuclear Receptor Subfamily 4, Group A, Member 2
  • Transcription Factors
  • Colforsin
  • Cyclic AMP
  • Mitogen-Activated Protein Kinases